ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1045

Acute Brain-Derived Neurotrophic Factor Response to Intradialytic Exercise During Hemodiafiltration: Role of Cognitive Reserve and Exercise Dose

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Garza Romero, Maria Fernanda, Instituto Nacional de Cardiologia Ignacio Chavez, State of Mexico, Mexico
  • Moedano Atristain, José Eduardo, Instituto Nacional de Cardiologia Ignacio Chavez, State of Mexico, Mexico
  • Flores Pérez, Cinthia Sofia, Instituto Nacional de Cardiologia Ignacio Chavez, State of Mexico, Mexico
  • Ramirez-Castillo, Normando, Universidad Nacional Autonoma de Mexico Facultad de Estudios Superiores Zaragoza, Mexico City, Mexico
  • Lara Díaz, Julieta, Instituto Nacional de Cardiologia Ignacio Chavez, State of Mexico, Mexico
  • Pérez Molina, Amado, Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz, Mexico City, Mexico
  • Cruz, Carlos, Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz, Mexico City, Mexico
  • Lopez-Gil, Salvador, Instituto Nacional de Cardiologia Ignacio Chavez, State of Mexico, Mexico
Background

Exercise training increases serum BDNF (brain-derived neurotrophic factor) in hemodialysis patients. Whether a single intradialytic session can modify this response, and whether cognitive function and exercise dose determine individual benefit, remains unknown.

Methods

Randomized, within-person crossover trial (n=24) in hemodiafiltration (HDF) patients. Participants completed one exercise session (90-min intradialytic cycling at cardiopulmonary exercise testing-guided intensity) and one control session. Serum BDNF was measured at 0, 90, and 180 min. A Bayesian linear mixed model examined the Montreal Cognitive Assessment (MoCA) and relative peak power output (W/kg) as moderators of the exercise-control difference over time.

Results

Mean age 40.9±13.2 years, 39% male, vintage 76.8±43.7 months, the most common etiology of kidney failure was unknown in 14 patients (58.3%), followed by glomerular disease in 5 (20.8%), and other causes in 4 (16.7%), with diabetic kidney disease in 1 (4.2%). MoCA 23.7±3.3, W/kg 0.46±0.30. BDNF declined during both sessions. Exercise had no overall effect on BDNF at 180 min (22% probability of benefit). The BDNF response at 180 min varied by cognitive reserve and exercise dose. Patients with mild cognitive impairment (MoCA<26) exercising above the group median W/kg (n=10) showed 3.0-fold higher BDNF at 180 min versus their own control session (95% credible interval: 1.03 to 9.4; posterior probability = 97.7%). This effect diminished progressively with increasing MoCA, was absent near MoCA=25, and favored the control session in cognitively intact patients (MoCA≥27).

Conclusion

Single-session intradialytic exercise does not modify BDNF on average. Patients with mild cognitive impairment who exercise at sufficient intensity show substantial neurotrophic preservation, identifying cognitive reserve and exercise dose as key determinants of response and supporting their use to individualize intradialytic exercise prescription.